<img src="//fp-live-discourse-bucket.s3.dualstack.eu-north-1.amazonaws.com/original/2X/1/115273f27fb3c45cfd5820163a6e8235a3de9386.jpeg"/>
<img src="//fp-live-discourse-bucket.s3.dualstack.eu-north-1.amazonaws.com/original/2X/1/115273f27fb3c45cfd5820163a6e8235a3de9386.jpeg"/>
Aktsiaturud suutsid reedel hoida pead vee pinnal ning panna punkti positiivsele nädalale. Kuigi tõusud polnud nõnda muljetavaldavad nagu nädal varem, õnnestus S&P 500 indeksil siiski trotsida nõrgemaid majandusnäitajaid ning pikendada võiduseeriat kolmandasse nädalasse, kui üheks toeavaks jõuks jäi debatt intressimäära tõstmise vajaduse üle.<br/> <br/><img src="//fp-live-discourse-bucket.s3.dualstack.eu-north-1.amazonaws.com/original/2X/f/f873bc9bcdc2b403d9e8b8b55cfa7dee74089213.png"/><br/><br/>Eesti aja järgi täna varahommikul avaldatud Hiina kolmanda kvartali SKP osutus oodatust pisut paremaks. Kui analüütikute prognooside vahemik oli 6,4-6,9% ning konsensuse oma 6,8%, siis tegelikuks numbriks osutunud 6,9% kujunes kardetust pisut tugevamaks, märkides esimese kahe kvartali 7,0% kõrval siiski väikest aeglustumist. <br/><br/>Sektoripõhises vaates on näha, et tööstussektoris aeglustus kasv teise kvartali 6,0% pealt 5,8% peale, samal ajal toetas majandust teenindussektor, kus kasv kiirenes 0,1pp võrra 8,6%ni (Bloombergi joonis värsket infot veel ei kajasta). Mõnevõrra on see üllatav, arvestades juunis alanud kukkumist kohalikul aktsiaturul, kuna esimesel poolaastal aitas pöörane aktsiate ostumaania suurenenud finantssektori aktiivsuse läbi lisada 7% SKP kasvu Citi andmetel tervelt 1,4 protsendipunkti. <br/><br/><img src="//fp-live-discourse-bucket.s3.dualstack.eu-north-1.amazonaws.com/original/2X/9/906b440c05daa19177530ce1396ec5d46fec6736.png"/><br/><br/>Paralleelselt avaldatud Hiina septembrikuu tööstustoodangu kasv aeglustus 6,1% pealt 5,7% peale (oodati 6,0%), üheksa kuu investeeringute kasv fikseeritud varadesse oli 10,3% (kaheksa kuu lõikes 10,9%), kuid jaemüügi kasv jäi stabiilseks (10,9% vs oodatud ning augustis registreeritud 10,8%), mis näitab, et aktsiaturgude korrektsioon pole tarbijatele olulist mõju avaldanud. <br/><br/><img src="//fp-live-discourse-bucket.s3.dualstack.eu-north-1.amazonaws.com/original/2X/7/709c60e85fe3da5add1e3d7d7d8b0411aa4c1a98.png"/><br/><br/>Hiina majandusnäitajad pakuvad täna peamist mõtteainet, kuna nii Euroopas kui ka Ühendriikides olulisi makronäitajaid oodata pole. Ettevõtetest avaldavad oma majandustulemused teiste seas Genuine Parts, Halliburton, Hasbro, Morgan Stanley, IBM.<br/><br/>16.00 Venemaa jaemüük, reaalpalga muutus, töötuse määr (september)<br/>17.00 USA majade ehitajate kindlustunde indeks (oktoober)<br/><br/><img src="//fp-live-discourse-bucket.s3.dualstack.eu-north-1.amazonaws.com/original/2X/f/ff528b71952ad3778d64ca99f7ab5bc57ca3f004.png"/>
Morgan Stanley headline numbrid jäävad oodatust nõrgemaks <br/><br/><i>Morgan Stanley prelim Q3 $0.34 vs $0.63 Capital IQ Consensus Estimate; revs $7.77 bln vs $8.46 bln Capital IQ Consensus Estimate</i>
Pealkirjad tänasest päevast 1987.a<br/><img src="//fp-live-discourse-bucket.s3.dualstack.eu-north-1.amazonaws.com/original/2X/4/4409adfd70bf57958fb5ed117889a12a07c980fe.png"/>
<b>Gapping Up:<br/></b><br/><b>In reaction to strong earnings/guidance:</b> None this morning<br/><br/><b>M&A news: </b>CCG +19.7% (to be acquired by Harrison Street Real Estate Capital for $7.03/share, or ~$1.9 bln), PMCS +13.3% (MSCC proposes to acquire PMCS for $11.50/share, or ~$2.4 bln; believes its offer constitutes a 'superior proposal' over the Skyworks (SWKS) deal), DBD +3.3% (in talks with Wincor Nixdorf regarding a potential business combination valued at roughly ~$1.8 bln).<br/><br/><b>Other news:</b> WTW +58.9% (partners with Oprah Winfrey; Winfrey will purchase newly issued shares representing 10% of the shares outstanding, and options to acquire an additional 5% of shares), CPXX +9.6% (announces Positive Recommendation from Data And Safety Monitoring Board for Phase 3 Study Of CPX-351), ZFGN +9.1% (continued volatility), PLX +7.8% (reports positive long term data on PRX-102 for fabry disease; meaningful clinical benefit demonstrated across all key disease parameters reversal in eGFR), OCN +7.5% (to voluntarily pay down $50 mln of its Senior Secured Term Loan Facility, will have ~$476.6 mln outstanding afterwards), PLUG +5.6% (announces that its average production of oil and natural gas was 2.72 mln barrels of oil equivalent per day in September vs. 2.88 mln boed produced in August), TSYS +2.6% (receives delivery order with a $91 mln ceiling contract value from U.S. Army for SNAP deployable satellite systems sustainment), DB +2.5% (reshuffles organizational structure, various upper management roles), NAT +2.5% (favorable commentary on Friday's Mad Money), TKC +1.7% (still checking), ARRS +1.1% (provides update on pending merger with Pace, warns the closing may not occur until late December or 1Q16). <br/><br/><b>Analyst comments</b>: DRI +0.6% (upgraded to Buy at Maxim Group; tgt $80).<br/><br/><br/><b>Gapping Down:<br/>In reaction to disappointing earnings/guidance:</b> MS -4.5% (missed on top and bottom lines; said volatility in global markets led to a difficult environment), VRX -2.3% (beats by $0.04, reports revs in-line; slightly raises Q4 guidance).<br/><br/><b>Other news:</b> GNCA -32.2% (reports top-line results from a Phase 2a clinical trial for GEN-004, neither of the endpoints achieved statistical significance), GLDD -15.6% (initiates a review of potential strategic alternatives, withdraws FY15 EBITDA guidance, announces the retirement of CEO Jonathan W. Berger), SDRL -5.8% (commented on investigation into Sevan Marine/Drilling, prior to SDRL acquisition), PBR -3.7% (announces that its average production of oil and natural gas was 2.72 mln barrels of oil equivalent per day in September vs. 2.88 mln boed produced in August), ZINC -2.8% (general weakness in mining), FCX -2.4% (general weakness in mining), SUNE -2.2% (still checking for anything specific), SHPG -1.1% (receives a Complete Response Letter from the FDA regarding the NDA for lifitegrast for the signs and symptoms of dry eye disease in adults), AGN -0.9% (presents results of its HARMONY study).<br/><br/><b>Analyst comments:</b> UBNT 3.3% (downgraded to Underperform at JMP Securities), ORCL -1.4% (downgraded to Sector Weight at Pacific Crest), TEF -1.3% (downgraded to Underperform from Neutral at Credit Suisse), STX -1.1% (downgraded to Neutral from Positive at Susquehanna).<br/><br/><br/>Briefing.com